MARKET

DRRX

DRRX

DURECT
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.170
+0.090
+4.33%
After Hours: 2.250 +0.08 +3.69% 18:33 02/21 EST
OPEN
2.070
PREV CLOSE
2.080
HIGH
2.250
LOW
2.050
VOLUME
978.20K
TURNOVER
--
52 WEEK HIGH
3.949
52 WEEK LOW
0.5000
MARKET CAP
417.43M
P/E (TTM)
-15.1325
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of DRRX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average DRRX stock price target is 4.720 with a high estimate of 6.00 and a low estimate of 2.100.

EPS

DRRX News

More
  • 3 “Strong Buy” Healthcare Stocks With Triple-Digit Upside
  • TipRanks · 02/10 13:05
  • Daily Insider Ratings Round Up 2/6/20
  • Seeking Alpha - Article · 02/08 13:23
  • 5 Stocks Under $5 With Colossal Growth Prospects
  • InvestorPlace · 01/31 16:14
  • Baird downgrades Amgen on soft guidance in premarket analyst action
  • Seeking Alpha - Article · 01/31 13:33

Industry

Biotechnology & Medical Research
+0.37%
Pharmaceuticals & Medical Research
+0.54%

Hot Stocks

Symbol
Price
%Change
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

About DRRX

Durect Corporation is a biopharmaceutical company with research and development programs. The Company's products candidates include DUR-928, oral for metabolic/lipid disorders, and DUR-928, injectable for acute organ injuries. Its other product candidates include POSIMIR (controlled release injection of bupivacaine), REMOXY (oral controlled release oxycodone), ORADUR-ADHD, ELADUR (controlled release injection of bupivicane), Relday (risperidone), ORADUR-based opioid (hydromorphone) and SABER-based ophthalmic. The Company's ALZET product line consists of miniature, implantable osmotic pumps and accessories used for experimental research in mice, rats and other laboratory animals. The Company also manufactures and sells osmotic pumps used in laboratory research and design; and develops and manufactures a range of standard and custom biodegradable polymers and excipients for pharmaceutical and medical device clients for use as raw materials in their products.
More

Webull offers kinds of DURECT Corporation stock information, including NASDAQ:DRRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DRRX stock news, and many more online research tools to help you make informed decisions.